RT Journal Article
SR Electronic
T1 Unbiased yeast screens identify cellular pathways affected in Niemann–Pick disease type C
JF Life Science Alliance
JO Life Sci. Alliance
FD Life Science Alliance LLC
SP e201800253
DO 10.26508/lsa.201800253
VO 3
IS 7
A1 Colaco, Alexandria
A1 Fernández-Suárez, María E
A1 Shepherd, Dawn
A1 Gal, Lihi
A1 Bibi, Chen
A1 Chuartzman, Silvia
A1 Diot, Alan
A1 Morten, Karl
A1 Eden, Emily
A1 Porter, Forbes D
A1 Poulton, Joanna
A1 Platt, Nick
A1 Schuldiner, Maya
A1 Platt, Frances M
YR 2020
UL https://www.life-science-alliance.org/content/3/7/e201800253.abstract
AB Niemann–Pick disease type C (NPC) is a rare lysosomal storage disease caused by mutations in either the NPC1 or NPC2 genes. Mutations in the NPC1 gene lead to the majority of clinical cases (95%); however, the function of NPC1 remains unknown. To gain further insights into the biology of NPC1, we took advantage of the homology between the human NPC1 protein and its yeast orthologue, Niemann–Pick C–related protein 1 (Ncr1). We recreated the NCR1 mutant in yeast and performed screens to identify compensatory or redundant pathways that may be involved in NPC pathology, as well as proteins that were mislocalized in NCR1-deficient yeast. We also identified binding partners of the yeast Ncr1 orthologue. These screens identified several processes and pathways that may contribute to NPC pathogenesis. These included alterations in mitochondrial function, cytoskeleton organization, metal ion homeostasis, lipid trafficking, calcium signalling, and nutrient sensing. The mitochondrial and cytoskeletal abnormalities were validated in patient cells carrying mutations in NPC1, confirming their dysfunction in NPC disease.